Trial intelligence / Profile preview

Liraglutide in PCOS

NCT02073929Phase 4Completed

Start
Mar 2014
Primary completion
Dec 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in polycystic ovary syndrome (PCOS). Started Mar 2014; status: completed.

02

Drugs

03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02073929.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02073929.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call